Sanofi is pausing orders for 50 milligram (mg) doses of respiratory syncytial virus (RSV) immunization nirsevimab (Beyfortus) and will have limited supply available when it reopens ordering. The announcement comes as federal officials established …
Melissa Jenco
Source link
